JACLYN COLLIE: Open Payments
NPI 1922509520 · LOXLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 42 payments from 15 companies in 2025. Trend: 2023 $1,491 · 2024 $1,361 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $210 |
| Novo Nordisk Inc | 9 | $142 |
| AstraZeneca Pharmaceuticals LP | 5 | $106 |
| Lilly USA, LLC | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Abbott Laboratories | 2 | $45 |
| Exact Sciences Corporation | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| PFIZER INC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: VRAYLAR, Ozempic, Wegovy, MOUNJARO, FANAPT, FREESTYLE LIBRE 3, FARXIGA, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
